
Envoy Medical rose 932.8% from $0.65 to $6.74, ahead of the S&P 500's +13.3%. Its worst day was Feb 12 (−20.5%), and its low came Feb 10 at $0.39.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Envoy Medical closed at its lowest level of the year, 40.2% below where the year started.
−17.1% · S&P 500 −0.3%
EPS of $-0.26 missed the $-0.24 estimate on $75,000.00 revenue (est. $30,000.00).
Story events cover the past 12 months · Times ET
−3.4% · S&P 500 +1.1%
EPS of $-0.08 beat the $-0.14 estimate on $39,000.00 revenue (est. $60,000.00).
−0.2% · S&P 500 +0.2%
EPS of $-0.07 beat the $-0.08 estimate on $51,000.00 revenue (est. $76,000.00).
+5.0% · S&P 500 0.0%
Envoy Medical shares rose 899.3%, while the S&P 500 fell 0.5%.
+899.3%, the year's best day · S&P 500 −0.5%
EPS of $-0.50 beat the $-0.68 estimate on $66,000.00 revenue (est. $80,000.00).
−0.3% · S&P 500 −4.4%
Where it ended: a close of $6.74 on Nov 13, 2026.
Nothing in the past 12 months.
All COCH dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for COCH and SPY from Benzinga historical bars. Not investment advice.